Coherus BioSciences, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
256.37 |
42.83 |
95.19 |
116.36 |
193.85 |
265.23 |
| Przychód Δ r/r |
0.00% |
-83.29% |
122.23% |
22.25% |
66.59% |
36.82% |
| Przychód (min) |
247.19 |
18.14 |
29.50 |
46.30 |
77.13 |
105.53 |
| Przychód (max) |
265.54 |
55.04 |
198.49 |
177.11 |
295.04 |
403.68 |
| EBITDA (średnia) |
-101.72 |
-16.99 |
-37.77 |
-46.17 |
-76.91 |
-105.23 |
| EBIT (średnia) |
-104.91 |
-17.53 |
-38.95 |
-47.62 |
-79.33 |
-108.53 |
| EBIT % |
-40.92% |
-40.92% |
-40.92% |
-40.92% |
-40.92% |
-40.92% |
| Zysk netto (średni) |
40.56 |
-156.90 |
-99.85 |
-92.44 |
-85.84 |
-41.34 |
| Zysk netto % |
15.82% |
-366.31% |
-104.90% |
-79.44% |
-44.28% |
-15.59% |
| EPS (średnia) |
0.35 |
-1.37 |
-0.82 |
-0.80 |
-0.75 |
-0.36 |
| Liczba analityków (Przychody) |
5 |
5 |
6 |
5 |
1 |
2 |
| Liczba analityków (EPS) |
4 |
2 |
4 |
4 |
3 |
2 |
| symbol |
CHRS |
CHRS |
CHRS |
CHRS |
CHRS |
CHRS |